Browse the full record of transactions filed by WILLIAMS FRANK J, Co-Founder and Former Chairman/Chief Executive Officer. Insider active across 1 companies, notably Evolent Health, Inc.. In total, 30 filings have been recorded. Total volume traded: €470k. The latest transaction was disclosed on 9 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
25 of 30 declarations
Frank J. Williams is widely known as a healthcare industry executive and corporate governance leader in the United States. He is most closely associated with Evolent Health, Inc., where he served as co-founder and held senior leadership roles over a long period. Public company disclosures and press releases describe him as Evolent’s former Chairman and Chief Executive Officer, and they note that he later retired from the company’s board in 2023. His affiliation with Evolent is the strongest and most verifiable part of his recent corporate profile. ([nasdaq.com](https://www.nasdaq.com/press-release/evolent-health-announces-dan-mccarthy-appointed-as-president-frank-j.-williams-to?utm_source=openai)) Before helping build Evolent, Williams led another major healthcare-focused organization: The Advisory Board Company. Public sources identify him as the company’s former Chairman and CEO. That role is important to understanding his career path, because it placed him at the intersection of healthcare strategy, research, and technology. His background is consistently associated with helping healthcare organizations adapt to value-based care models, improve operating performance, and use data and technology to support better clinical and financial outcomes. ([prnewswire.com](https://www.prnewswire.com/news-releases/healthcare-technology-leader-joins-verantos-strategic-advisory-board-301539106.html?utm_source=openai)) At Evolent, Williams was part of the leadership team that built the company into a recognized platform for clinical and administrative healthcare solutions. Public materials suggest that he played a central role in shaping the company’s strategic direction during its growth phase and in establishing its position in the U.S. healthcare market. He is commonly described as a seasoned executive with deep experience in healthcare transformation, provider and payer partnerships, and the operational challenges of scaling a value-based care business. ([nasdaq.com](https://www.nasdaq.com/press-release/evolent-health-announces-dan-mccarthy-appointed-as-president-frank-j.-williams-to?utm_source=openai)) Williams’ notable contributions appear to be less about a single headline decision and more about sustained leadership across multiple organizations. His career reflects repeated involvement in building healthcare platforms, guiding strategy, and supporting governance at companies operating in complex regulated markets. He has also been referenced in public profiles as a board-level contributor and advisor within the broader healthcare innovation ecosystem, underscoring his reputation as an executive with expertise in commercial strategy, healthcare services, and organizational transformation. ([prnewswire.com](https://www.prnewswire.com/news-releases/healthcare-technology-leader-joins-verantos-strategic-advisory-board-301539106.html?utm_source=openai))